(Q45479619)

14 December 2017

title

Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). (English)

1 reference

14 December 2017

main subject

transmembrane protein

0 references

1 reference

1 reference

Langhammer S

1

1 reference

14 December 2017

Fiebig U

series ordinal

2

1 reference

14 December 2017

Kurth R

series ordinal

3

1 reference

14 December 2017

Denner J

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

23

1 reference

14 December 2017

issue

25

1 reference

14 December 2017

page(s)

3341-3348

1 reference

The frequency of occurrence of feline leukaemia virus subgroups in cats

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

The occurrence of feline leukaemia virus neutralizing antibodies in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Feline leukaemia virus: a review of immunity and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Present status of human HIV vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

The HIV Env-mediated fusion reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Multiepitope vaccines intensively increased levels of antibodies recognizing three neutralizing epitopes on human immunodeficiency virus-1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Induction of high level of specific antibody response to the neutralizing epitope ELDKWA on HIV-1 gp41 by peptide-vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Immunosuppression by retroviruses: implications for xenotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.091

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.01.091

1 reference

14 December 2017

1 reference